A Nashville doctor helped pioneer an FDA approved "state-of-the-art" gene-editing therapy that could be a cure for painful ...

Millions of older Americans taking GLP-1 receptor agonists such as tirzepatide and semaglutide for weight loss may be losing ...

Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has granted priority review to the company’s supplemental ...

US FDA grants Priority Review to Roche’s Gazyva/Gazyvaro for adults with primary membranous nephropathy: Basel Thursday, July 16, 2026, 09:00 Hrs [IST] Roche announced that the ...

Pneumonia can affect people of all ages, but older adults are at a much higher risk of developing severe illness and ...

The clinical trials reviewed by the FDA found that adding Lipfendra to statin therapy reduced LDL cholesterol by approximately 56% to 60%.

An experimental antibody designed to briefly block the immune checkpoint PD-L1 in the brain has cleared its first human ...

Ultra-processed food heart disease risk: A 2026 modeling study presented at ICO 2026 in Mexico City estimates that 23–38% of ...

Section deals with the comprehensive list of drugs approved by FDA in 2026. Drug information includes the drug name and indication of use.

Sustained heat stress is bad for our health and can be deadly. But we’re discovering that heat therapies like sauna, when ...

We checked in with 10 sleep companies that appeared on Shark Tank to see where they are today—and asked former Shark Mark ...

As people with HIV live longer, diabetes is becoming an increasingly important contributor to morbidity and mortality, ...